The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids

Nidhi M. Sagar, Henri Duboc, Gemma L. Kay, Mohammad T. Alam, Alfian N. Wicaksono, James A. Covington, Christopher Quince, Margarita Kokkorou, Vaios Svolos, Lola J. Palmieri, Konstantinos Gerasimidis, Julian R.F. Walters, Ramesh P. Arasaradnam

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Bile acid diarrhoea (BAD) is a common disorder resulting from increased loss of bile acids (BAs), overlapping irritable bowel syndrome with diarrhoea (IBS-D). The gut microbiota metabolises primary BAs to secondary BAs, with differing impacts on metabolism and homeostasis. The aim of this study was to profile the microbiome, metabolic products and bile acids in BAD. Patients with BAD diagnosed by SeHCAT testing, were compared with other IBS-D patients, and healthy controls. Faecal 16S ribosomal RNA gene analysis was undertaken. Faecal short chain fatty acid (SCFA) and urinary volatile organic compounds (VOCs) were measured. BAs were quantified in serum and faeces. Faecal bacterial diversity was significantly reduced in patients with BAD. Several taxa were enriched compared to IBS-D. SCFA amounts differed in BAD, controls and IBS-D, with significantly more propionate in BAD. Separation of VOC profiles was evident, but the greatest discrimination was between IBS-D and controls. Unconjugated and primary BA in serum and faeces were significantly higher in BAD. The faecal percentage primary BA was inversely related to SeHCAT. BAD produces dysbiosis, with metabolite differences, including VOC, SCFA and primary BAs when compared to IBS-D. These findings provide new mechanistic insights into the pathophysiology of BAD.

Original languageEnglish
Article number20436
JournalScientific Reports
Volume10
Issue number1
DOIs
Publication statusPublished - Dec 2020

Cite this